Biovie Inc.
BIVI· Nasdaq
Filed Aug 13, 2026 · 10-K · 44 days after period end · 0001520138-26-000332
derived · Computed from the longer spans the company filed.
| Metric | Q4 2026dderived from reported figures | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$5.65M | -$3.49M | -$4.94M | -$9.11M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 13, 2026 · 44 d after period end